In the Review Article entitled “Investigations and management of chronic cough: a 2020 update from the European Respiratory Society Chronic Cough Task Force” published in the September 2020 issue (Farooqi MAM, Cheng V, Wahab M, et al. Pol Arch Intern Med. 2020; 130: 789-795. doi:10.20452/pamw.15484), on page 793, in the Refractory or unexplained chronic cough section, the sentence “In clinical practice, most patients are unable to tolerate such high dosage used in RCTs, hence it is recommended to start at 100 mg 3 times a day with gabapentin and 50 to 75 mg twice a day and to increase slowly on a weekly basis.” should have read “In clinical practice, most patients are unable to tolerate such high dosage used in RCTs, hence it is recommended to start at 100 mg 3 times a day with gabapentin and 50 to 75 mg twice a day with pregabalin and to increase slowly on a weekly basis.”
The article is correct at www.mp.pl/paim.